Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome (CACTuS)
Primary Purpose
Amyloidosis Cardiac, Carpal Tunnel Syndrome
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
DPD Scintigraphy
Sponsored by
About this trial
This is an interventional diagnostic trial for Amyloidosis Cardiac
Eligibility Criteria
Inclusion Criteria:
- Patients above sixty years of age previously operated for idiopathic carpal tunnel syndrome within the Region of Central Denmark (Region Midtjylland) the last five years.
- Informed written and verbal consent
Exclusion Criteria:
Operation by different indication such as
- Fracture
- Ganglion
- Tumors
- Osteophytes
- Rheumatoid Arthritis
- Persistent medial artery
- Metabolic causes
- Alcoholism
- Hyperthyroidism
Myxedema
- Hereditary Cardiac Amyloidosis
- Known WT ATTR
- AL Amyloidosis
- Myelomatosis
- MGUS and Morbus Waldenström
Sites / Locations
- Department of Heart Disease
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Suspicion of cardiac amyloidosis
Arm Description
Patients who display signs of cardiac amyloidosis will be referred for further diagnosis.
Outcomes
Primary Outcome Measures
Prevalence of cardiac amyloidosis.
The prevalence of cardiac amyloidosis among patients previously operated for ipiopathic carpal tunnel syndrome.
Secondary Outcome Measures
Full Information
NCT ID
NCT03996382
First Posted
June 17, 2019
Last Updated
October 1, 2021
Sponsor
Aarhus University Hospital Skejby
Collaborators
Regional Hospital Holstebro
1. Study Identification
Unique Protocol Identification Number
NCT03996382
Brief Title
Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome
Acronym
CACTuS
Official Title
Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
June 17, 2019 (Actual)
Primary Completion Date
December 1, 2020 (Actual)
Study Completion Date
December 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aarhus University Hospital Skejby
Collaborators
Regional Hospital Holstebro
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Wild-type transthyretin cardiac amyloidosis is an underdiagnosed depository disease in which fibril monomers of misfolded amyloid protein accumulates in various tissues, including the heart, and cause tissue dysfunction.
Before onset of cardiac symptoms, many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand.
This study investigates patients previously operated for idiopathic carpal tunnel syndrome to determine if they display signs and symptoms of cardiac amyloidosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amyloidosis Cardiac, Carpal Tunnel Syndrome
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Suspicion of cardiac amyloidosis
Arm Type
Other
Arm Description
Patients who display signs of cardiac amyloidosis will be referred for further diagnosis.
Intervention Type
Diagnostic Test
Intervention Name(s)
DPD Scintigraphy
Intervention Description
Confirms/Refutes diagnosis of cardiac amyloidosis.
Primary Outcome Measure Information:
Title
Prevalence of cardiac amyloidosis.
Description
The prevalence of cardiac amyloidosis among patients previously operated for ipiopathic carpal tunnel syndrome.
Time Frame
Through study completion, an average of 2 years.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients above sixty years of age previously operated for idiopathic carpal tunnel syndrome within the Region of Central Denmark (Region Midtjylland) the last five years.
Informed written and verbal consent
Exclusion Criteria:
Operation by different indication such as
Fracture
Ganglion
Tumors
Osteophytes
Rheumatoid Arthritis
Persistent medial artery
Metabolic causes
Alcoholism
Hyperthyroidism
Myxedema
Hereditary Cardiac Amyloidosis
Known WT ATTR
AL Amyloidosis
Myelomatosis
MGUS and Morbus Waldenström
Facility Information:
Facility Name
Department of Heart Disease
City
Aarhus
ZIP/Postal Code
8200
Country
Denmark
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome
We'll reach out to this number within 24 hrs